Literature DB >> 34045823

Total knee arthroplasty in dialysis patients: Is it safe? A systematic review of the literature.

Ioannis Gkiatas1, William Xiang1, Theofilos Karasavvidis2, Eric N Windsor3, Abhinav K Sharma3, Peter K Sculco1.   

Abstract

PURPOSE: This systematic review characterizes the safety and efficacy of total knee arthroplasty (TKA) in end stage renal disease (ESRD) patients due to the unique challenges they face.
RESULTS: The cumulative complication rate for 3684 patients on dialysis for ESRD after primary TKA was 25%(N = 925/3702), with incidence rates of 2.5%(N = 92/3702) for periprosthetic joint infection, 3.7%(N = 71/1895) for reoperations, and 2.5%(N = 90/3578) for mortality.
CONCLUSION: Patients on dialysis for ESRD face significant mortality rates after primary TKA, in addition to other major complications. Careful counseling regarding risks and benefits should be provided prior to TKA in this population.
© 2021 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Complications; Dialysis; Renal failure; Total knee arthroplasty

Year:  2021        PMID: 34045823      PMCID: PMC8144102          DOI: 10.1016/j.jor.2021.05.025

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  38 in total

1.  Past incidence and future demand for knee arthroplasty in Sweden: a report from the Swedish Knee Arthroplasty Register regarding the effect of past and future population changes on the number of arthroplasties performed.

Authors:  O Robertsson; M J Dunbar; K Knutson; L Lidgren
Journal:  Acta Orthop Scand       Date:  2000-08

2.  Rates of infection and revision in patients with renal disease undergoing total knee replacement in Scotland.

Authors:  M A McCleery; W J Leach; T Norwood
Journal:  J Bone Joint Surg Br       Date:  2010-11

3.  Hospital Length of Stay following Primary Total Knee Arthroplasty: Data from the Nationwide Inpatient Sample Database.

Authors:  Youssef F El Bitar; Kenneth D Illingworth; Steven L Scaife; John V Horberg; Khaled J Saleh
Journal:  J Arthroplasty       Date:  2015-05-08       Impact factor: 4.757

4.  The mid-term outcome of dialysis-dependent patients undergoing primary total knee arthroplasty and total hip arthroplasty: A retrospective study.

Authors:  I-Ning Lo; Shang-Wen Tsai; Po-Kuei Wu; Cheng-Fong Chen; Ming-Chau Chang; Wei-Ming Chen
Journal:  J Chin Med Assoc       Date:  2019-02       Impact factor: 2.743

5.  Mortality After Total Knee Arthroplasty: A Systematic Review of Incidence, Temporal Trends, and Risk Factors.

Authors:  James R Berstock; Andrew D Beswick; José A López-López; Michael R Whitehouse; Ashley W Blom
Journal:  J Bone Joint Surg Am       Date:  2018-06-20       Impact factor: 5.284

6.  Incidence and reasons for nonrevision reoperation after total knee arthroplasty.

Authors:  Benjamin Zmistowski; Camilo Restrepo; Lauren K Kahl; Javad Parvizi; Peter F Sharkey
Journal:  Clin Orthop Relat Res       Date:  2011-01       Impact factor: 4.176

7.  Dialysis Dependence Predicts Complications, Intensive Care Unit Care, Length of Stay, and Skilled Nursing Needs in Elective Primary Total Knee and Hip Arthroplasty.

Authors:  Joseph T Patterson; Kyle Tillinghast; Derek Ward
Journal:  J Arthroplasty       Date:  2018-02-17       Impact factor: 4.757

8.  Septic arthritis in haemodialysis patients: a seven-year multi-centre review.

Authors:  S S Al-Nammari; V Gulati; R Patel; N Bejjanki; M Wright
Journal:  J Orthop Surg (Hong Kong)       Date:  2008-04       Impact factor: 1.118

9.  Is dialysis vintage a perioperative risk for end-stage renal disease patients receiving total knee and hip arthroplasty.

Authors:  Yi-Chia Wang; Ya-Jung Cheng; Ju-Yeh Yang; Chia-Der Chao; Jenq-Wen Huang; Kuan-Yu Hung
Journal:  J Orthop Surg (Hong Kong)       Date:  2019 May-Aug       Impact factor: 1.118

10.  Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range.

Authors:  Xiang Wan; Wenqian Wang; Jiming Liu; Tiejun Tong
Journal:  BMC Med Res Methodol       Date:  2014-12-19       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.